Enter assignee name

% Expired Patents = 20.0

CIPO Patents = 1

EPO Patents = 7

Forward Citations = 20

Loading Chart...

9 inventors (with patents filed for the assignee):

David Lawson Morris (9 out of 24 patents)

Roger Aston (7 out of 9 patents)

Mohammad Hossein Pourgholami (5 out of 5 patents)

4. Nobuharu Andoh (3 out of 7 patents)

5. Osamu Sanpei (3 out of 6 patents)

6. Tetsuo Toga (3 out of 3 patents)

7. Tomokazu Hino (3 out of 7 patents)

8. Koji Tanaka (3 out of 26 patents)

9. Richard Mollard (1 out of 1 patent)

10 patents: Sort by Forward Citations

1. 12213957 - Use of aminoacetonitrile compounds for the treatment of infection and disease (2025-02-04),

2. 10391076 - Anti-cancer agent comprising aminoacetonitrile compound as active ingredient (2019-08-27),

3. 10292960 - Anticancer agent comprising aminoacetonitrile compound as active ingredient (2019-05-21),

4. 10053422 - Compounds for the treatment of mTOR pathway related diseases (2018-08-21),

5. 9907778 - Anticancer agent comprising aminoacetonitrile compound as active ingredient (2018-03-06),

6. 9833431 - Pharmaceutical combinations for the treatment of cancer (2017-12-05),

7. 9790176 - Compounds for the treatment of mTOR pathway related diseases (2017-10-17),

8. 9308193 - Kinase inhibitors for the treatment of cancer (2016-04-12),

9. 8912225 - VEGF inhibition (2014-12-16),

10. 8835478 - Treatment for cancer (2014-09-16),

Pitney Pharmaceuticals Pty Limited is a pharmaceutical company based in Claremont, Australia, specializing in the development and manufacturing of innovative therapeutic solutions. The organization focuses on a range of medical applications, emphasizing research in drug formulation and delivery systems. With a commitment to advancing healthcare, Pitney Pharmaceuticals aims to address unmet medical needs through its specialized expertise in pharmaceuticals, ensuring high-quality products that enhance patient outcomes.

Profile summary based on public USPTO records.